Showing results 406 to 425 of 761
< previous
next >
| Issue Date | Title | Author(s) |
| 2022-04-13 | Managing Apoptosis in Lung Diseases Using Nano-Assisted Drug Delivery System. | Shukla, MK; Dubey, A; Pandey, S; Singh, SK; Gupta, G; Prasher, P; Chellappan, DK; Oliver, BG; Kumar, D; Dua, K |
| 2019-04-01 | MAPK pathway: A potential target for the treatment of non-small-cell lung carcinoma | Pradhan, R; Singhvi, G; Dubey, SK; Gupta, G; Dua, K |
| 2021-06-23 | Material and strategies used in oncology drug delivery | Verma, N; Thapa, K; Dua, K |
| 2018-03-01 | Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of bacteria isolated from pharmaceutical clean rooms | Andrade, LDO; Awasthi, R; Dua, K; Andreoli Pinto, TDJ |
| 2022-03-27 | Mechanism of mesenchymal stem cells as a multitarget disease-modifying therapy for parkinson's disease. | Unnisa, A; Dua, K; Kamal, MA |
| 2017-07-01 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma | Hansbro, PM; Kim, RY; Starkey, MR; Donovan, C; Dua, K; Mayall, JR; Liu, G; Hansbro, NG; Simpson, JL; Wood, LG; Hirota, JA; Knight, DA; Foster, PS; Horvat, JC |
| 2021-07-31 | Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases | Verma, N; Dua, K; Sarin, A |
| 2021-05-29 | Medicinal Plants for Lung Diseases A Pharmacological and Immunological Perspective | Dua, K; Nammi, S; Chang, D; Chellappan, DK; Gupta, G; Collet, T |
| 2021-05-29 | Medicinal Plants for Lung Diseases A Pharmacological and Immunological Perspective | Dua, K; Nammi, S; Chang, D; Chellappan, DK; Gupta, G; Collet, T |
| 2021-05-29 | Medicinal Plants for Lung Diseases A Pharmacological and Immunological Perspective | Dua, K; Nammi, S; Chang, D; Chellappan, DK; Gupta, G; Collet, T |
| 2021-07-31 | Medicinal Plants in the Treatment of Tuberculosis III | Rawat, S; Raizaday, A; Pathak, S; Singh, H; Mishra, A; Singh, SK; Dua, K; Gupta, G |
| 2021-07-31 | Medicinal Plants Used in Treatment of Bronchitis | Pathak, M; Singh, L; Mishra, GP; Dua, K; Majhi, S |
| 2021 | Metabiotics in Colorectal Cancer: Crosstalk Between Gut Microbiota and Host Pathology | Gulati, M; Singh, SK; Kumar, R; Dua, K; Panda, S; Blaxland, J; Chandwani, L |
| 2023-04 | Metal‐based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy | Kumar, S; Shukla, MK; Sharma, AK; Jayaprakash, GK; Tonk, RK; Chellappan, DK; Singh, SK; Dua, K; Ahmed, F; Bhattacharyya, S; Kumar, D |
| 2020-01 | Microbial determinants of arthritis. | Shukla, SD; Shastri, MD; Jha, NK; Dua, K |
| 2016-08-01 | The microbial quality aspects and decontamination approaches for the herbal medicinal plants and products: An in-depth review | Ghisleni, DDM; Braga, MDS; Kikuchi, IS; Braşoveanu, M; Nemţanu, MR; Dua, K; Pinto, TDJA |
| 2018-08-01 | Microbiome as therapeutics in vesicular delivery | Singhvi, G; Girdhar, V; Patil, S; Gupta, G; Hansbro, PM; Dua, K |
| 2022 | Microbiome in Idiopathic Pulmonary Fibrosis | Pathak, S; Mishra, A; Gupta, G; Raizaday, A; Singh, SK; Kumar, P; Singh, SK; Jha, NK; Chellappan, DK; Dua, K |
| 2019-06-01 | Microbiome-focused asthma management strategies | Shukla, SD; Shastri, MD; Chong, WC; Dua, K; Budden, KF; Mahmood, MQ; Hansbro, NG; Keely, S; Eri, R; Patel, RP; Peterson, GM; Hansbro, PM |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
